Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05592145 · ClinicalTrials.gov registry record · NA
Quantifying the Venous Congestion Curve of a Tissue Oximetry Device
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT05592145 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 38 participants.
The verdict
NCT05592145, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this research study is to measure rate of decline and pattern of tissue oxygenation using the device, ViOptix T.Ox. ViOptix probes will be secured to the arm and hand. The recording process on the ViOptix machine will begin and obtain baseline StO2 levels for 5 minutes. After 5 minutes, a blood pressure cuff will be inflated on one arm. This blood pressure cuff will be left inflated for 10-20 minutes. Every 2 minutes a pulse check or doppler exam will be performed at your wrist. Last, the cuff will be deflated and the you will be free to leave the study room.
Interventions
- DEVICE ViOptix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2023-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05592145
The ClinicalTrials.gov registry entry for NCT05592145 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ViOptix is the first listed.
NCT05592145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05592145 about?
NCT05592145 is a clinical study titled "Quantifying the Venous Congestion Curve of a Tissue Oximetry Device". The purpose of this research study is to measure rate of decline and pattern of tissue oxygenation using the device, ViOptix T.Ox. ViOptix probes will be secured to the arm and hand. The recording process on the ViOptix machine will begin and obtain baseline StO2 levels for 5 minutes. After 5 minut...
What is the current status of trial NCT05592145?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2022-11-10. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT05592145?
The interventions under investigation include: ViOptix (DEVICE).
Who is sponsoring clinical trial NCT05592145?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.